ロード中...
Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes
INTRODUCTION: Ki-67 labeling index assessed by immunohistochemical assays has been shown useful in assessing the risk of recurrence for estrogen receptor (ER)-positive HER2-negative breast cancers (BC) and distinguishing Luminal A-like from Luminal B-like tumors. We aimed to assess the performance o...
保存先:
| 出版年: | Breast Cancer Res Treat |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6797656/ https://ncbi.nlm.nih.gov/pubmed/31422497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-019-05402-w |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|